When brassinosteroid levels are low, the GSK3-like kinase BIN2 phosphorylates and inactivates the BZR1 transcription factor to inhibit growth in plants. Brassinosteroid promotes growth by inducing dephosphorylation of BZR1, but the phosphatase that dephosphorylates BZR1 has remained unknown. Here, using tandem affinity purification, we identified protein phosphatase 2A (PP2A) as a BZR1-interacting protein. Genetic analyses demonstrated a positive role for PP2A in brassinosteroid signalling and BZR1 dephosphorylation. Members of the B' regulatory subunits of PP2A directly interact with BZR1's putative PEST domain containing the site of the bzr1-1D mutation. Interaction with and dephosphorylation by PP2A are enhanced by the bzr1-1D mutation, reduced by two intragenic bzr1-1D suppressor mutations, and abolished by deletion of the PEST domain. This study reveals a crucial function for PP2A in dephosphorylating and activating BZR1 and completes the set of core components of the brassinosteroid-signalling cascade from cell surface receptor kinase to gene regulation in the nucleus.
kinase domain 16 , allowing association with the co-receptor kinase BRI1associated receptor kinase 1 (BAK1; ref. 17 ). Autophosphorylation and sequential transphosphorylation between BRI1 and BAK1 fully activate the BRI1 kinase [17] [18] [19] , initiating a cascade of signal transduction events, including BRI1 phosphorylation of the brassinosteroid-signalling kinase 1 (BSK1) at its Ser 230 residue 20 , BSK1 binding to the PP1-related protein phosphatase BRI1 suppressor 1 (BSU1), and BSU1 dephosphorylation of BIN2 at phospho-Tyr 200, which inactivates BIN2 kinase 4 . Following BIN2 inactivation, BZR1 and BZR2 are dephosphorylated by an unknown phosphatase 9 , and they translocate into the nucleus to regulate a large number of brassinosteroid target genes, which are involved in a wide range of functions 1, 7 ( Supplementary Fig. S1a ).
The brassinosteroid signalling pathway is distinct from animal steroid signalling pathways, which use nuclear receptor transcription factors 21 , but shares similarities with the metazoan Wnt signalling pathway, in which the GSK3 kinase inactivates β-catenin and a PP1 phosphatase inactivates GSK3 (ref. 11) . In the Wnt pathway, PP2A dephosphorylates β-catenin, counteracting the effect of GSK3 (refs 11,22,23) . The phosphatase that dephosphorylates BZR1/2 is the last major component of the brassinosteroid signalling pathway yet to be identified 1, 9 ( Supplementary Fig. S1a ). In this study, we demonstrate that PP2A dephosphorylates BZR1 in the brassinosteroid signalling pathway.
RESULTS

BZR1 interacts with PP2A
To identify the BZR1-dephosphorylating phosphatase, we carried out tandem affinity purification of BZR1-interacting proteins followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS; see Methods). Protein extracts of transgenic Arabidopsis thaliana seedlings expressing BZR1-7Myc-6His or bzr1-1D-7Myc-6His were purified using Ni affinity column followed by immunoprecipitation using antic-myc antibody. The purified proteins were identified by LC-MS/MS. Proteins specifically co-purified with BZR1 or bzr1-1D include several known BZR1-interacting proteins such as 14-3-3λ (ref. 12) , BIN2, and SHAGGY-like kinases AtSK12 and AtSK31 (ref. 4) , indicating that our purification was successful ( Supplementary Fig. S2a ). In addition, several peptides that match different subunits of PP2A, including PP2A A subunits (roots curl in naphthylphthalamic acid1 (RCN1)/PP2AA1, PP2AA2 and PP2AA3) and PP2A B subunits (PP2AB η, PP2AB β and PP2AB θ), were also identified in the purification of BZR1 or bzr1-1D complexes ( Supplementary Fig. S2a-c) .
As a heterotrimeric serine/threonine phosphatase, the PP2A holoenzyme is composed of a catalytic C subunit, a scaffolding A subunit, and a regulatory B subunit that determines substrate specificity and PP2A subcellular localization 24 . Recent structural studies of holoenzyme complexes indicate that the B subunits provide an exposed concave surface for substrate recruitment adjacent to the active site of the C subunit 25 . As in other multicellular eukaryotes, Arabidopsis PP2A B subunits can be further grouped into B, B and B subfamilies 26 .
As mass spectrometry analysis of the BZR1 complex identified partial sequences that match several isoforms of PP2A A and B subunits, we used yeast two-hybrid assays to determine which PP2A subunits directly interact with BZR1. We found that specific members of the B subunit subfamily interacted directly with BZR1 in yeast two-hybrid assays ( Fig. 1a ), whereas no interaction was detected between BZR1 and PP2A A subunits or C subunits ( Supplementary Fig. S3a ). BZR2, the close homologue of BZR1, also interacts with PP2A B α and β ( Supplementary  Fig. S3b ). On the basis of the interaction strength with BZR1, PP2AB family proteins can be further classified into three groups: strong BZR1 interactors (B α, β, γ and κ), weak interactors (B η, θ and ζ) and noninteractors (B δ and ε; Fig. 1a ). In vitro overlay assays showed that recombinant PP2AB α binds to phosphorylated BZR1 more strongly than to unphosphorylated BZR1, whereas BIN2 binds to unphosphorylated BZR1 more strongly, consistent with stronger binding to substrates than products ( Fig. 1b) . These interactions were further confirmed in vivo by bi-molecular fluorescence complementation (BiFC) assays. Tobacco epidermal cells co-transformed with PP2AB α, β or η fused to the amino-terminal half of yellow fluorescent protein (YFP; B α, β, η-nYFP) and BZR1 fused to the carboxy-terminal half of cyan fluorescent protein (BZR1-cCFP) showed strong fluorescence signals, whereas tobacco cells co-transformed with PP2AB ε-nYFP and BZR1-cCFP showed no fluorescence signal (Fig. 1c ). These results indicate that BZR1 directly interacts with several isoforms of PP2A B . The PP2A scaffolding A subunits were most likely purified together with BZR1 as constituents of PP2A complexes recruited by B subunit binding. To further confirm that B subunit binding brings BZR1 to the PP2A holoenzyme in vivo, we used co-immunoprecipitation assays to detect BZR1 association with PP2A catalytic subunits (Fig. 1d ). These results indicate that direct binding to the B subunit in vivo promotes BZR1 association with PP2A holoenzymes containing A, B and C subunits.
Overexpression of PP2A increases BZR1 activity and suppresses brassinosteroid-insensitive mutants
To test whether PP2A can dephosphorylate BZR1 and activate brassinosteroid responses in planta, we generated transgenic Arabidopsis plants overexpressing either PP2A B α or PP2A B β, B subunits that showed strong interaction with BZR1 in yeast. These plants showed reduced sensitivity to the brassinosteroid biosynthetic inhibitor brassinazole (BRZ), with long hypocotyls on BRZ similar to the bzr1-1D mutant ( Fig. 2a ). Overexpression of PP2A B α and PP2A B β also partially suppressed the phenotypes of the weak allele bri1-5 ( Fig. 2b-d and Supplementary Fig. S4a -c). Analysis by real-time quantitative PCR with reverse transcription (qRT-PCR) showed the transcript level of the BZR1-repressed target gene constitutive photomorphogenic dwarf (CPD) was increased in the bri1-5 mutant, but reduced by overexpression of PP2A B α and B β ( Fig. 2c and Supplementary  Fig. S4c ). Consistent with the effects on growth and target gene expression, BZR1 accumulation was increased in plants overexpressing PP2AB β or PP2AB α ( Fig. 2e ). Interestingly, both unphosphorylated and phosphorylated BZR1 levels were increased, indicating that binding to PP2A B protects BZR1 from degradation, but may not be sufficient for dephosphorylation. It is possible that some of the overexpressed B proteins are not associated with the catalytic subunits. Overexpression of PP2A B β and PP2A B α also partly suppressed the null mutant bri1-116 ( Fig. 2f and Supplementary Fig. S4d ) and the homozygous gain-of-function bin2-1 mutant (Fig. 2g ). The bin2-1 mutant is suppressed by bzr1-1D, but not by overexpression of upstream components BSK3 and BSU1 (ref. 5; Fig. 2g ). In the dark-grown bin2-1 mutant, only phospho-BZR1 was detected, whereas a small amount of unphosphorylated BZR1 was detectable in wildtype plants. The transgenic bin2-1 plants overexpressing PP2AB β accumulated unphosphorylated BZR1 at a level similar to that observed in the wild type ( Supplementary Fig. S4e ). These data are consistent with PP2A acting on BZR1 downstream of or parallel to BIN2 in the brassinosteroid signal transduction pathway.
PP2A activity is required for normal BZR1 dephosphorylation and plant growth
To determine whether PP2A is required for BZR1 dephosphorylation and brassinosteroid signalling in planta, we obtained transferred DNA (T-DNA) insertion mutants for several PP2A B and C subunits 27 . Of the pp2ab family mutants screened (α, β, γ, η, θ and ζ), only the pp2ab β mutant showed slightly reduced responses to brassinosteroid in hypocotyl elongation and root inhibition in the light ( Supplementary Fig. S5a,b ). When grown in the dark on normal medium or on BRZ, hypocotyls of the pp2ab β mutant seedlings were slightly shorter than wild type ( Supplementary  Fig. S5c ), consistent with reduced brassinosteroid sensitivity. The T-DNA insertion mutant of PP2A catalytic subunit C5 (pp2ac5) also had shorter hypocotyls when grown on medium containing BRZ ( Supplementary Fig. S5d ,e) and showed increased expression of the BZR1-repressed target genes DWARF 4 (DWF4) and CPD, consistent with reduced brassinosteroid signalling (Supplementary Fig. S5f ). The phenotypes of these B and C subunit single-gene mutants are subtle, presumably because of redundant functions of other gene family members. Therefore, we generated pp2ab αβ double mutants lacking the two major BZR1-binding PP2A B isoforms. In the pp2ab αβ double-mutant populations, a variety of phenotypes were observed ranging from near wild type to severe dwarfism (Fig. 3a) . The levels of PP2A B β RNA were inversely correlated with the degree of dwarfism ( Supplementary Fig. S6 ), indicating that loss of both PP2A B α and B β causes dwarfism. The variation of PP2A B β RNA level in the double mutant is probably due to variable efficiencies of splicing of the T-DNA together with the intron. Immunoblot analysis showed that the pp2ab αβ double-mutant plants exhibiting the dwarf phenotype accumulate an increased level of phosphorylated BZR1 protein and slightly reduced level of unphosphorylated BZR1 (Fig. 3b ). When grown in the dark, many pp2ab αβ seedlings showed an obvious short-hypocotyl phenotype, whereas wild-type seedlings are uniformly tall (Fig. 3c ). These results indicate that loss of two BZR1-interacting B subunits of PP2A (B α and B β) reduces BZR1 dephosphorylation and plant growth.
Brassinosteroid-induced BZR1 dephosphorylation is also incomplete in the rcn1 pp2aa3 double mutants, which showed severe dwarfism, with some similarity to bri1-116 and bin2-1 mutants ( Supplementary  Fig. S5g,h) . These results support a crucial role for PP2A in BZR1 dephosphorylation. However, the rcn1 pp2aa3 double mutant lacks two of the three scaffolding subunits, is severely defective in regulation of auxin transport 28, 29 and is expected to grossly overproduce ethylene 30, 31 . The dwarf phenotypes of the rcn1 pp2aa3 double mutant reflect a marked reduction in overall PP2A activity level; however, this doublemutant combination does not directly affect the subunits involved in recruiting BZR1 for dephosphorylation. The radial expansion exhibited by rcn1 pp2aa3 hypocotyls is not characteristic of brassinosteroidinsensitive dwarfs ( Supplementary Fig. S5g ), but is characteristic of ethylene overproducers. Similarly, the primary root meristem collapse exhibited by rcn1 pp2aa3 double mutants is not characteristic of brassinosteroid insensitivity, but is a hallmark of severe defects in root auxin transport 29 . In contrast, the B subunit mutants described above have stronger effects on BZR1 phosphorylation patterns and more specific effects on brassinosteroid signalling (compare Fig. 3b and Supplementary Fig. S5g,h) .
Treatment with the PP2A inhibitor okadaic acid inhibited brassinosteroid-induced BZR1 dephosphorylation ( Fig. 3d ) and nuclear localization 32 . As okadaic acid can also inhibit the BSU1 phosphatase 33 and thus lead to increased BIN2 activity, the increase in phosphorylated BZR1 after okadaic acid treatment could be due to increased phosphorylation by BIN2 or reduced dephosphorylation by PP2A. To avoid effects on BSU1-mediated regulation of BIN2, we used bin2-1 mutant plants, in which the bin2-1 kinase is constitutively active and insensitive to BSU1 regulation 4 . We also took advantage of the recently identified GSK3 kinase inhibitor bikinin 34 , which inhibits both BIN2 and bin2-1 kinases. Bikinin treatment caused accumulation of unphosphorylated BZR1 by inhibiting bin2-1 phosphorylation without affecting the dephosphorylating phosphatase. In the presence of okadaic acid, the bikinin-induced accumulation of dephosphorylated BZR1 is significantly decreased (Fig. 3e ), indicating that okadaic acid affects BZR1 dephosphorylation downstream of BIN2, consistent with inhibition of PP2A-mediated BZR1 dephosphorylation.
PP2A interacts with BZR1 through its PEST domain, which is essential for brassinosteroid-induced BZR1 dephosphorylation in vivo
Although the loss-of-function mutants of various PP2A subunits provided strong evidence for a role of PP2A in BZR1 dephosphorylation, these mutants either show a weak phenotype due to redundant function of a large numbers of isoforms 35 or pleotropic phenotypes due to multiple functions of PP2A in a wide range of processes. We thus investigated whether the interaction with and dephosphorylation by PP2A could be disrupted by mutations in BZR1. First, we carried out yeast two-hybrid assays using fragments of BZR1 containing known functional domains (Fig. 4a,b ) to identify the region that is necessary and sufficient for binding to PP2AB α (amino acids 215-251). This region contains the putative proline-, glutamic-acid-, serine-and threonine-rich (PEST) domain proposed to be involved in protein Supplementary Fig. S9 . degradation 8, 10 . Deletion of amino acids 232-251 in the full-length BZR1 ( PEST) abolished the interaction with PP2AB α in yeast (Fig. 4b ). We then generated transgenic Arabidopsis plants expressing either wild-type BZR1-YFP or a mutant BZR1 PEST -YFP fusion protein.
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In the absence of exogenous brassinosteroid, the BZR1 PEST protein accumulated exclusively in the phosphorylated form, whereas a significant portion of the wild-type BZR1 was unphosphorylated or hypophosphorylated (Fig. 4c ). Brassinosteroid treatment caused complete dephosphorylation of the wild-type BZR1-YFP protein but very little change in the mutant BZR1-YFP proteins (Fig. 4c ). Deletion of a larger domain (amino acids 215-251) had similar effects on PP2A binding and in vivo dephosphorylation ( Supplementary  Fig. S7a-c) . Thus, dephosphorylation of BZR1 by PP2A is greatly compromised by the PEST deletion. These results demonstrate that PP2AB binds to BZR1 through a specific PP2A-binding domain, and this binding is essential for brassinosteroid-induced dephosphorylation of BZR1 in vivo. Interestingly, the transgenic plants that overexpress the BZR1 PEST protein showed reduced plant size with dark green leaves ( Supplementary Fig. S7d ), similar to brassinosteroid-deficient mutants, indicating that phosphorylated BZR1 may have an inhibitory effect on brassinosteroid response. This would be consistent with the dwarf phenotype of the pp2ab αβ double mutant, in which the levels of phospho-BZR1 increase markedly but dephosphorylated BZR levels decrease only slightly (Fig. 3a ). Phospho-BZR1 may inhibit cell elongation through a cytoplasmic process or by interference with nuclear localization of unphosphorylated BZR1 protein.
Binding to PP2A is enhanced by the bzr1-1D mutation and reduced by two intragenic bzr1-1D suppressor mutations
The PP2A-binding domain of BZR1 defined above includes the residue altered by the bzr1-1D mutation, Pro 234 (ref. 8; Fig. 4a ). We thus tested whether the bzr1-1D mutation (P234L) affects the interaction with PP2A and dephosphorylation of BZR1. Although the bzr1-1D mutation subtly alters the migration of BZR1 protein 9 , a larger fraction of the mutant bzr1-1D protein is present in the unphosphorylated form when compared with wild-type BZR1 (Fig. 4d ). Furthermore, in vitro binding assays revealed that the bzr1-1D mutation increased binding to PP2AB α (Fig. 4e) . These results indicate that bzr1-1D increases BZR1 dephosphorylation by PP2A. To test this hypothesis, we identified two intragenic bzr1-1D suppressors (bzs247 and bzs248) that suppressed the BRZ-resistant phenotypes of the bzr1-1D mutant (Fig. 4f) , as a result of mutations near the original bzr1-1D mutation (T236I and E242K; Fig. 4a ). Both bzs mutations also partly reversed the dephosphorylation change caused by bzr1-1D (Fig. 4g) , and reduced binding of bzr1-1D to PP2AB α (Fig. 4h) . In contrast, the binding of BIN2 was not affected by bzr1-1D or the bzs247 and bzs248 mutations (Fig. 4h) . These genetic and biochemical results demonstrate that the effect of the bzr1-1D mutation on brassinosteroid signalling is due to increased binding between BZR1 and PP2A, which leads to accumulation of dephosphorylated BZR1.
Dephosphorylation by PP2A abolishes BZR1 binding to the 14-3-3 proteins
The preceding experiments identified the PP2A binding site of BZR1, but did not identify the target site(s) for PP2A-mediated BZR1 dephosphorylation. BZR1 contains 25 putative BIN2 phosphorylation sites 12, 14 . Phosphorylation of one of these sites, Ser 173, promotes 14-3-3 binding and cytoplasmic retention 12 . To determine whether PP2A dephosphorylates all residues phosphorylated by BIN2 and affects 14-3-3 binding, we treated BIN2-phosphorylated BZR1 with PP2A immunopurified from transgenic plants. Immunoprecipitation of the scaffolding A subunit (RCN1-YFP or PP2A A3-YFP) yielded immunocomplexes that dephosphorylated BZR1. BSU1 immunoprecipitates had no BZR1-dephosphorylating activity (Fig. 5a ). PP2A immunoprecipitated from brassinosteroid-treated and untreated plants showed similar activity against phospho-BZR1 in vitro (Fig. 5a ).
In vitro phosphorylation by BIN2 markedly alters SDS-polyacrylamide gel electrophoresis (PAGE) migration of BZR1 and promotes strong binding to the 14-3-3λ protein. Both the mobility shift and 14-3-3 protein binding were abolished after incubation with immunopurified PP2A (Fig. 5b) , indicating that PP2A can dephosphorylate many or all BIN2 phosphorylation sites, including the 14-3-3 binding site at Ser 173. Pre-incubation with 14-3-3 had little effect on PP2A dephosphorylation of BZR1 (Fig. 5c ), which is consistent with the separate binding sites for 14-3-3 and PP2A. These data indicate that one critical effect of PP2A action on BZR1 is to relieve the 14-3-3-mediated cytoplasmic retention of Ser-173-phosphorylated BZR1. PP2A action probably relieves other inhibitory effects of BIN2 phosphorylation on BZR1 function, such as DNA binding. PP2AB α and B β are localized in the cytoplasm ( Supplementary Fig. S8) , consistent with the hypothesis that PP2A acts on cytoplasmically retained phospho-BZR1. These results demonstrate that PP2A antagonizes BIN2 effects in the brassinosteroid signalling pathway by dephosphorylating BIN2-phosphorylated BZR1.
DISCUSSION
This study not only reveals a key role of the PP2A phosphatase in steroid response in plants, but also elucidates a detailed mechanism of PP2A regulation of BZR1 function. The in vivo interaction between PP2A and BZR1 was demonstrated by affinity purification, BiFC and co-immunoprecipitation assays. Direct interactions with specific regulatory B subunits were verified by both in vitro and in vivo assays, and the interaction was shown to be mediated by direct binding to the PEST domain of BZR1. The function of PP2A in dephosphorylating BZR1 and activating brassinosteroid responses in plants was demonstrated by overexpression and loss-of-function mutants of PP2A, as well as by mutations of the PP2A-binding domain in BZR1. Interaction in yeast indicates that PP2A also regulates BZR2 through similar mechanisms. The combination of these biochemical and genetic data demonstrates that PP2A is a key component of the brassinosteroid signalling pathway, activating brassinosteroid responses by dephosphorylating BZR transcription factors. PEST domains in many proteins are known to mediate protein degradation. Whereas the PEST domains in BZR1 and BZR2 were previously proposed to mediate their degradation 9,10 , our data show that this region functions as a PP2A-binding domain. The stabilizing effect of the bzr1-1D mutation in the PEST domain could be due to increased dephosphorylation by PP2A, as previous studies indicated that phosphorylation promotes BZR1 degradation by the proteasome 9 . However, there have been conflicting observations of whether brassinosteroid treatment increases or decreases the levels of BZR1 and BZR2 (refs 9,10,13) . Alternatively, binding to PP2A might directly affect BZR1 stability and phosphorylation status, as indicated by the accumulation of higher levels of both phosphorylated and unphosphorylated BZR1 in plants overexpressing PP2A B α or B β, and the increased level of phosphorylated BZR1 in the pp2ab αβ double mutant. Deletion of the PEST domain reduced dephosphorylation of BZR1 in vivo, but had little effect on total BZR1 accumulation. Whether the PEST domain also plays a direct role in BZR1 turnover remains to be analysed in future studies.
Together with the previously characterized components 1,4 , PP2A completes a core signalling module that relays the extracellular brassinosteroid cue to the nucleus, regulating BZR1 activity and gene expression in plants ( Supplementary Fig. S1b ). When brassinosteroid levels are low, BZR1 is phosphorylated by BIN2 in the nucleus 9, 13, 32 , and consequently exported from the nucleus and retained in the cytoplasm by 14-3-3 proteins 12, 36 . When brassinosteroid binds to BRI1, sequential activation of BSK1 and BSU1 leads to tyrosine dephosphorylation and inactivation of BIN2 (refs 5,20) , whereas BZR1 is rapidly dephosphorylated by PP2A in the cytoplasm and moves into the nucleus to activate and repress different target genes 7 . Consistent with their functions in driving BZR1 in and out of the nucleus, PP2AB α and B β are localized predominantly in the cytoplasm ( Supplementary  Fig. S8 ), and BIN2 has been shown to act more effectively in the nucleus than in the cytoplasm 13, 32 . In contrast, BSU1 is present in both cytoplasm and nucleus 5, 32 , presumably to be activated by BSK1 at the plasma membrane and to inactivate BIN2 in the nucleus. It remains unclear whether brassinosteroid only inactivates BIN2 or also activates PP2A to promote accumulation of unphosphorylated BZR1. As an abundant cellular phosphatase, PP2A is involved in many processes, such as regulation of gravitropic response and auxin transport 28, 29 and phototropic responses 37 . Whether PP2A is constitutively active in brassinosteroid response or regulated by any signal remains to be demonstrated in future studies.
This study provides further evidence for intriguing similarities between the brassinosteroid pathway in plants and the Wnt pathway in metazoans 11 , because recent studies demonstrated a role for PP2A in dephosphorylating and activating β-catenin 23 . In both brassinosteroid and Wnt pathways, GSK3 phosphorylates and inactivates transcription factors (BZR1 and β-catenin) and PP2A counteracts these effects by dephosphorylating the GSK3 substrates 23 , whereas PP1 and related phosphatases (BSU1) play a positive role upstream of GSK3 (refs 4, 11,38; Supplementary Fig. S1b ). Another similar interplay between PP2A and 14-3-3 was reported recently for the regulation of forkhead box transcription factor O3a (FOXO3a) nuclear localization and transcription activation in humans 39 . Further studies of the detailed signalling mechanisms of each system will be required to understand whether there was an evolutionary convergence or conservation of signalling modules of these pathways in the two kingdoms. For hypocotyl and root growth assays, seedlings were grown on vertical agar plates containing half-strength Murashige and Skoog medium supplemented with 1% sucrose. For short-duration hormone treatments, the seedlings were submerged in hormone or mock solution for the times of treatment shown.
METHODS
Methods
Tandem affinity purification of BZR1-interacting proteins. Arabidopsis thaliana
Columbia transformed with 35S::BZR1-7Myc-6His, 35S::bzr1-1D-7Myc-6His or pBZR1::BZR1-CFP, pBZR1::bzr1-1D-CFP were grown on solid Murashige and Skoog medium supplemented with 3% sucrose for two weeks, then harvested and ground to fine powder in liquid nitrogen. The tissues were extracted using a buffer containing 50 mM PBS, 150 mM NaCl, 1% Triton X-100, 15% glycerol, 5 mM imidazole and protease inhibitor cocktails (Sigma) at 4 • C. The homogenate was centrifuged at 14,000g for 10 min and the supernatant was incubated with Ni-NTA agarose beads (Qiagen) for 30 min at 4 • C. The beads were washed on a column with 20 bed volumes of wash buffer 1 (50 mM PBS, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol, 5 mM imidazole) and then eluted with elution buffer (50 mM PBS, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol, 80 mM imidazole). Proteins eluted from the Ni-NTA beads were incubated with anti-Myc antibody agarose (Sigma) for 30 min at 4 • C. After washing with a 200 bed volume of washing buffer 2 (50 mM PBS, 150 mM NaCl, 0.1% Triton X-100 and 10% glycerol), the proteins were eluted twice by boiling in 1% SDS for 5 min, and then separated in a 5-20% gradient SDS-PAGE gel. Each gel lane was cut into 20 pieces, then in-gel digested with trypsin and analysed by LC-MS/MS as described previously 40 . Proteins identified in the BZR1-Myc-His samples but not in the BZR1-CFP samples are considered real BZR1-interacting proteins.
Yeast two-hybrid assays, co-immunoprecipitation and BiFC experiments.
These procedures were carried out as described previously 4, 12 . Anti-BZR1 antibody was produced by immunizing rabbits with a maltose binding protein (MBP)-tagged full-length BZR1 protein. The antibody was affinity purified using a glutathione S-transferase (GST)-tagged BZR1 fragment (amino acids 91-336) without the conserved DNA binding domain. As BZR1 and BZR2 share 88% amino-acid sequence identity, this antibody detects recombinant BZR2 protein; it also detects increased signal in the dominant bzr1-1D and bes1-D mutants. Therefore, the signal detected by this antibody includes both BZR1 and BZR2. Anti-PP2A C antibody was described previously 30 . The purified antibody was diluted to 0.5 mg l −1 for immunoblot analysis.
Protein expression and purification. GST-tagged PP2AB α, PP2AB β, BIN2 and MBP-tagged BZR1, bzr1-1D, bzs247 and bzs248 were expressed in Escherichia coli and purified by a standard procedure using glutathione agarose beads (GE Healthcare) or amylose agarose beads (New England Biolabs). BIO-RAD Profinity eXact fusion-tag system was used to generate tag-free BIN2 for in vitro MBP-tagged BZR1 phosphorylation. In brief, a PCR-amplified BIN2 complementary DNA was cloned into the BamH I/EcoRI site of pPAL7 (BIO-RAD) expression vector, and the plasmid was introduced into the BL21 codon plus E. coli cells. Tag-free BIN2 protein was induced and purified according to manufacturer's protocol using a Profinia protein purification system (BIO-RAD).
In vitro interaction assay using gel blot overlay assays. To prepare phosphorylated BZR1, 2 µg MBP-tagged BZR1 was incubated with 2 µg tag-free BIN2 in the presence or absence of 200 µM ATP for 16 h at 30 • C. Phosphorylated and unphosphorylated BZR1 protein were then separated on a SDS-PAGE gel and blotted on nitrocellulose membrane. The membrane was incubated in blocking solution (5% non-fat milk and 0.1% Tween-20 in PBS) overnight at 4 • C. The membrane was then incubated in blocking solution plus 2 µg ml −1 GST-tagged PP2AB α, PP2AB β, 14-3-3λ or BIN2 for 2 h at room temperature, washed briefly for 30 min, followed by 1 h incubation at room temperature with horseradish-peroxidase-labelled anti-GST antibody in blocking solution. Overlay signal was detected using the SuperSignal West Dura chemiluminescence reagent (Pierce).
Overexpression of PP2A B α and B β. Full-length cDNAs of PP2AB α and PP2AB β without a stop codon were amplified by PCR using gene-specific primers (B α-For, 5 -caccATGTTTAAGAAGATCATGAAAG-3 ; B α-Rev, 5 -AGAAGTGATCATAGGATCTTCTCTTTC-3 ; B β-For, 5 -caccATGTTTAAGAAA ATCATGAAAG-3 ; B β-Rev, 5 -GGAAGTGATCATATGATCTTCTTCTC-3 ; lowercase letters are nucleotides added for cloning). The cDNAs were cloned into pENTR/SD/D-TOPO vectors (Invitrogen), and subcloned into gateway-compatible binary vectors pEarleyGate 104 or BiFC vectors 12 by LR clonase (Invitrogen). To create the PEST construct, site-directed mutagenesis was carried out according to the manufacturer's protocol (Stratagene) to delete the sequence coding for amino acids 232-251 from the BZR1 entry clone. The primers used for mutagenesis were, forward: 5 -CACATCGCCACCAGTTTCATTGGATAAGCTTTCAG-3 ; reverse: 5 -CTGAAAGCTTATCCAATGAAACTGGTGGCGATGTG-3 .
The mutagenized cDNA was cloned into the gateway-compatible binary vectors pEarleyGate 101 by LR clonase (Invitrogen).
The constructs were introduced into Agrobacterium tumefaciens strain GV3101 by electroporation and transformed into Arabidopsis by the floral dipping method. To test genetic interactions between BRI1, BIN2 and PP2AB α or PP2AB β, a single 35S::PP2AB α or 35::PP2AB β-YFP transgenic plant was crossed into the bri1-116 and bin2-1 mutants. The phenotypes of F3 double-homozygous plants were analysed. qRT-PCR analysis of the CPD and DWF4 gene expression was carried out as described previously 10 . 
